MD

"Our next goal is to elucidate the whole picture of the interactions between renin cells, smooth muscle cells, nerves and inflammatory cells under RAS inhibition," said researcher Maria Luisa S. Sequeira-Lopez, MD.

"This class of drugs continue to show benefits far beyond weight loss," said researcher Christopher Kramer, MD, chief of UVA Health's Division of Cardiovascular Medicine.

Edward Chang, MD, the chair of Neurological Surgery at UCSF, said these insights could revolutionize care for people with epilepsy.

Cullen was also part of that trial along with his colleague Bryan Allen, MD, PhD, UI professor and head of radiation oncology.

The researchers hope to build and expand on these initial discoveries, said the study's senior author Malik Kahook, MD, professor of ophthalmology at the CU School of Medicine.